Circulating endothelial cells are an early predictor in renal cell carcinoma for tumor response to sunitinib

BACKGROUND: Tyrosine kinase inhibitors (TKI) have enriched the therapeutic options in patients with renal cell carcinoma (RCC), which frequently induce morphological changes in tumors. However, only little is known about the biological activity of TKI. Circulating endothelial cells (CEC) have been a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gruenwald, Viktor, Beutel, Gernot, Schuch-Jantsch, Susanne, Reuter, Christoph, Ivanyi, Philipp, Ganser, Arnold, Haubitz, Marion
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023793/
https://www.ncbi.nlm.nih.gov/pubmed/21194438
http://dx.doi.org/10.1186/1471-2407-10-695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023793/
https://www.ncbi.nlm.nih.gov/pubmed/21194438
http://dx.doi.org/10.1186/1471-2407-10-695

Ejemplares similares